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Abstract
The gut microbiota is an essential regulator of many aspects of host physiology. Disruption of gut microbial
communities affects gut-brain communication which ultimately can manifest as changes in brain function and
behaviour. Transient changes in gut microbial composition can be induced by various intrinsic and extrinsic factors,
however, it is possible that enduring shifts in the microbiota composition can be achieved by perturbation at a
timepoint when the gut microbiota has not fully matured or is generally unstable, such as during early life or ageing. In
this study, we investigated the effects of 3-week microbiota depletion with antibiotic treatment during the adolescent
period and in adulthood. Following a washout period to restore the gut microbiota, behavioural and molecular
hallmarks of gut-brain communication were investigated. Our data revealed that transient microbiota depletion had
long-lasting effects on microbiota composition and increased anxiety-like behaviour in mice exposed to antibiotic
treatment during adolescence but not in adulthood. Similarly, gene expression in the amygdala was more severely
affected in mice treated during adolescence. Taken together these data highlight the vulnerability of the gut
microbiota during the critical adolescent period and the long-lasting impact manipulations of the microbiota can have
on gene expression and behaviour in adulthood.
Introduction
The adolescent period is a key developmental period
which marks the transition from childhood to adult-
hood. It is during this last developmental stage before
adulthood that the brain is highly responsive to certain
environmental cues that will shape neuronal archi-
tecture and promote maturation of social behaviours,
emotional and cognitive capabilities and is hence a
vulnerable period for the onset of psychiatric diseases1.
The gut microbiota composition of an adolescent is
usually simpler and more unstable when compared with
that of an adult, which is highly diverse and stable2,3.
These differences are probably due to relative
immaturity of the gut microbiota during the adolescent
period, which makes it more vulnerable to environ-
mental stressors such as infection, use of antibiotic and
poor diet. In addition to this, gonadal hormones are
peaking during the puberty and it has been shown to
have a long-term on the microbiota diversity1,4. Overt
changes in the gut microbiota composition might
therefore contribute to the onset of such disease and
could be targeted by the use of biotherapeutics, anti-
biotics or different types of diet2,5,6. Nonetheless, the
consequences of gut microbiota manipulation during
adolescence is yet to be fully understood.
The gastrointestinal tract is colonised by trillions of
bacteria that are tightly associated with host physiology.
When the equilibrium of the microbial milieu in the gut is
shifted it can have long-lasting effects on whole-body
health including the brain and behaviour7–11. In mam-
mals, the initial microbiota is obtained during the birthing
process and develops alongside its host from a rather
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instable to a highly stable and diverse community in
adulthood2,12. Microbiota composition during the devel-
opmental period is shaped by a combination of genetic
and environmental factors to be highly adapted to the
host and the host’s environment12. However, maladapta-
tion of the gut microbiota could affect key innate and
adaptative immune signalling within the intestine and at
sites anatomically remote such as the brain resulting in
altered host response to infection and vaccination as well
as increase the susceptibility to brain disorders2,13. For
example, altered gut microbiota composition can imme-
diately affect brain function by impacting the turnover
and release of neurotransmitters, hormones as well as
growth factors and consequently affect behavioural
parameters and thereby increase the susceptibility to
develop neuropsychiatric disorders5,14–17.
One way to study the perturbation of the gut micro-
biota during critical periods is by using antibiotic-
induced depletion. Antibiotics are one of the most
important factors influencing the gut microbiota com-
position and structure. Studies in both female and male
mice and rats16,18–20 and humans21,22 have shown that
antibiotic administration can induce changes in phy-
siology, brain and behaviour. Antibiotic depletion of the
microbiota for a defined time period represents an
advantage in comparison to classic approach such as
germ-free (GF) animals as the effects of microbiota
depletion during the early developmental period can be
avoided23,24. It has been shown, that the use of anti-
biotics to chronically deplete the intestinal microbiota
during adulthood has been associated with hormonal
changes and alterations in gene expression, decreased
adult hippocampal neurogenesis, and changes anxiety-
related responses, exploratory behaviour, and cognitive
abilities20,25,26. Moreover, early life exposure to anti-
biotics induces long-lasting increases in visceral pain
responses27 as well as altered metabolic programming18.
We have previously shown that microbiota depletion
with antibiotics commencing in adolescence all the way
through adulthood resulted in deficits in anxiety and
cognitive behaviour25. It is not clear whether such
changes are a result of microbiota changes specifically in
adolescence, in adulthood or a combination.
Thus, in these experiments, we investigated the con-
sequences of gut microbiota depletion specifically dur-
ing adolescence or adulthood and their associated long-
term effects on emotional and cognitive behaviours and
related-neurochemical measures. The use of ABX allows
us to ask specific questions that are unattainable using
GF mice. Moreover, as ABX usage can be high in ado-
lescence (e.g. in acne management)28 it allows us to have
a more translationally relevant manipulation than GF
animals.
Experimental procedure
Animals and experimental design
Adolescent and adult male C57Bl/6OlaHsd mice
(Envigo, UK) were housed 4 per cage in standard cages.
All mice were housed in our animal facility and main-
tained under a 12-h light/dark cycle. All experiments were
conducted in accordance with the European Directive 86/
609/EEC. Approval by the Animal Experimentation Ethics
Committee of University College Cork (2012 #45) and
Health Products Regulatory Authority were obtained
before commencement of all experiments. To comply
with 3Rs (reduction, refinement and replacement) and
animal welfare, the adolescent aspect of the experiment
was run simultaneously with another experiment inves-
tigating the gut microbiota29. The same control group was
used in this study.
In order to sufficiently deplete the gut microbiota, a
wide-spectrum antibiotic cocktail (ABX) consisting of
ampicillin (1 g/L, CAS no. 69-52-3), vancomycin (0.5 g/L,
CAS no. 1404-93-9), ciprofloxacin HCL (0.2 g/L, CAS no.
93107-08-5), imipenem (0.25 g/L, CAS no. 74431-23-5)
and metronidazole (1 g/L, CAS no. 443-48-1) was pre-
pared (Fig. 1B)20,29. All substances were purchased from
Discovery Fine Chemicals, UK. This antibiotic cocktail
has little to no oral bioavailability and was prepared
freshly with autoclaved water every second day for
3 weeks (Fröhlich et al., 2016). Control mice received
autoclaved water (CTRL). Mice were treated during
adolescence (P28-P49) or adulthood (P76-97) and will be
referred to as ABXadolescence and ABXadulthood, respectively
(see Fig. 1A). Adolescence period in mice was defined as
from the day where mice become sexually active (P28)30.
Behavioural tests commenced 24 days after the final
antibiotic exposure. Mice were equally assigned to
experimental groups based on body weight to ensure
equally distribution among the groups. Each cage repre-
sented one treatment. Behavioural tests investigating
aspects of anxiety, cognition, social behaviour and fear
conditioning were chosen as these behaviours have been
shown to be affected by alterations in gut microbiota
composition and structure8,31–33. Tissue samples were
collected 24 h after the last behavioural test. Body weight
was monitored throughout the experiment. The investi-
gators who were involved in sample processing and data
analysis were blinded to the groups. All behaviours were
assessed by two independent scorers blind to the groups.
See supplemental methods for detailed information of all
procedures and analysis run in this study.
Elevated plus maze
The elevated plus maze (EPM) was used to investigate
anxiety-like behaviours29. Mice were allowed to explore
the maze for 5 min; the time spent in the open arms, as
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well as the number of entries into the arms and head dips,
were analysed.
Novel object recognition task
Novel object recognition task (NORT) is a test for
short-term memory25. Mice were exposed to two identical
objects which they could explore for 10min. One hour
later they were exposed to a familiar and a new object.
The time they spent exploring the new object was taken as
an indication of their memory function.
Three-chamber social approach test
Sociability and social novelty were investigated using
the three-chamber social interaction test (3CSIT)29. The
test consisted of three sequential 10-min trials: (1) habi-
tuation, (2) sociability, measured as the time the mouse
spent in proximity to a conspecific or an object and (3)
social novelty preference as measured by the time the
mouse spent with an unfamiliar conspecific or a familiar
one.
Differential fear-conditioning paradigm
Fear conditioning (FC) is based on pairing an initially
neutral and non-aversive stimulus, an auditory cue or
context (conditioned stimulus, CS), with an aversive
stimulus, such as a foot shock (unconditioned stimulus,
US), which will result in a fear response in the presence
of the CS34. The paradigm was run over 4 consecutive
days: day 1 (context A): conditioning, day 2 (context A):
contextual extinction, day 3 (context B): conditioned
extinction in a novel context, day 4 (context B): context
recall.
RNA extractions, reverse transcription and quantitative RT-
PCR
Whole amygdala and prefrontal cortex were rapidly
gross-dissected on an ice-cooled Petri dish following
coordinates described in the “The Mouse Brain in Ste-
reotaxic Coordinates”35 and snap-frozen on dry-ice. For
consistency, the same experienced researcher was
responsible for all the dissection. These brain regions
were chosen as they are major contributor to anxiety and
fear learning (amygdala) and proper neuronal commu-
nication during development (prefrontal cortex)36–41. The
list of genes was elaborated together with the experi-
mental design to assess major components modulated by
the gut microbiota, such as immune and microglia-related
markers, tight-junction proteins and myelin- and stress-
related genes8,29,32,39,40. In addition, based on the beha-
vioural phenotype, we included genes associated with
anxiety-like behaviour such as the genes involved in the
GABAergic and glutamatergic system, NPY system and
genes related to neuroplasticity8,26,29,33,36. Primer
sequences are listed on the Supplementary Table S1.
Total RNA was extracted with the mirVana total RNA
extraction kit (Ambion, UK) and RNA was reverse tran-
scribed using a high-capacity cDNA reverse transcription
kit (Thermo Fisher Scientific, Waltham, USA) in a G-
storm thermocycler (G-storm, Surrey, UK). Real-time
PCR was performed on the cDNA samples using SYBR
green (SensiFAST™ SYBR®, BioLine, UK) and gene
expression levels were analysed on an AB7300 system
(Applied Biosystems, Thermo Fisher Scientific, USA).
Expression levels were calculated as the average of three
replicates for each biological sample from all three groups
Fig. 1 Experimental design and body weight performance during the experiment. A Schematic representation of the experimental timeline.
Numbers represent the age of the mice at that specific timepoint. B List of drugs used for the antibiotic cocktail. C, D Changes in body weight during
adolescence (C) and adulthood (D) over the time course of the experiment. ABX-treated mice show a significant body weight loss on PND10 which is
restored afterwards. Mean ± SEM. *p < 0.05. Sample size for adolescence: CTRL n= 12 and ABX n= 10, adults: CTRL and ABX n= 11. Two-way
repeated measures ANOVA followed by Sidak’s post hoc test. PND: postnatal day, CTRL: control, ABX: antibiotic, 3CSIT: three-chambered social
interaction test, NORT: novel object recognition task, EPM: elevated plus maze, FC: fear conditioning, Beh: behavioural test.
Lach et al. Translational Psychiatry          (2020) 10:382 Page 3 of 16
relative to the endogenous control. Fold changes were
calculated using the ΔΔCt method29. The expression of
the housekeeper ACTB was not affected by ABX treat-
ment or age.
Caecal microbiota composition (16S rRNA gene sequecing)
The QIAmp Fast DNA Stool Mini Kit (Qiagen, Sussex,
UK) was used for caecal DNA extraction. The procedure
was coupled with an initial bead-beating step. Amplification
and preparation for sequencing of the V3-V4 hypervariable
region of the 16S rRNA gene were done as outlined in the
Illumina 16S Metagenomic Sequencing Library Protocol
and as previously described29. Briefly, microbial genomic
DNA was run with each primer (forward primer (5′-
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGC
CTACGGGNGGCWGCAG-3′) and reverse primer (5′-
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG
GACTACHVGGGTATCTAATCC-3′). PCR products were
purified using the Agencourt AMPure XP system (Beckman
Coulter Genomics, UK). Dual indices and Illumina
sequencing adapters were attached to PCR products using
the Nextera XT Index Kit (Illumina, USA). PCR products
were quantified, normalized and pooled in an equimolar
fashion using the Qubit® dsDNA HS Assay Kit (Life
Technologies, USA). Following, samples were run on the
Agilent Bioanalyser for quality analysis and samples pre-
pared for sequencing following Illumina guidelines. Samples
were sequenced on the MiSeq sequencing platform (Clin-
ical Microbiomics, Denmark).
Microbiome bioinformatics processing
Three-hundred base-pair paired-end reads were pre-
filtered based on a quality score threshold of >28 and
trimmed, filtered for quality and chimaeras using the
DADA2 library in R42. Samples with fewer than 10,000
reads after trimming and filtering were dropped. Tax-
onomy was assigned with DADA2 against the SILVA
SSURef database release v132. Parameters, as recom-
mended in the DADA2 manual, were adhered to unless
mentioned otherwise. ASVs that were only detected as
non-zero in 2 or fewer of total samples were excluded.
Statistics
Power analysis was performed beforehand using the
Software G*Power 3.1 to ensure adequate sample size
number to detect changes in behaviour and gene
expression. Statistical analysis and plotting were con-
ducted using Prism 7 (GraphPad, USA). Data were
checked for normality using Shapiro–Wilks normality test
while the ROUT method [50] was used to check for
outliers. Two-tailed Student’s t-test (for equal variances)
or Welch’s t-test (for unequal variances) were used for
comparison between CTRL and ABX for the EPM,
NORT, context and extinction recall in FC, and gene
expression. Mann–Whitney nonparametric test was used
when dataset failed to have a normal distribution. Two-
way repeated measures analysis of variance (ANOVA) was
used for body weight, 3CSIT, as well as acquisition and
cued extinction in FC. Sidak’s multiple comparisons post
hoc test was used where applicable. Statistical significance
was set at p < 0.05.
Statistical analysis of microbiota data was performed
using the R software (version 3.6) environment with
Rstudio (version 1.1.453). Alpha diversity was calculated
using the iNEXT library43. Wilcoxon rank sum followed
by Bonferroni post hoc tests were used to assess differ-
ences in Alpha-diversity scores. For principal component
analysis (PCA), permutational multivariate analysis of
variance (PERMANOVA) was used to identify relation-
ships of significance between variables using the adonis()
function from the vegan library on Aitchison distance
matrices calculated with the ALDEx2 library44. A pairwise
implementation of the ALDEx2 function aldex.t.test() was
also used to calculate pairwise differential abundance,
using the Bonferroni procedure as a post hoc. In the case
of microbiome analysis, the Benjamini–Hochberg proce-
dure was used to account for false discovery rate due to
multiple comparisons, a q-value of 0.1 was deemed
significant.
Results
Antibiotic treatment in adolescence affects body weight
Two-way repeated measures ANOVA showed an overall
effect of ABX treatment during adolescence on body weight
(interaction F(3,48)= 3.84, p= 0.015, treatment F(1,16)=
7.18, p= 0.017), whereas such an effect was not seen fol-
lowing treatment with ABXadulthood (interaction F(3,60)=
12.56, p < 0.001, treatment F(1,20)= 0.11, p= 0.75; Fig. 1C,
D). Sidak’s multiple comparison, however, revealed that
body weight was significantly lower in the ABX treatment in
both ABXadolescence and ABXadulthood mice on day 10 of the
treatment (p= 0.003 and p= 0.05, respectively). On day 10,
the body weight loss in ABX-treated mice compared to the
CTRL was 14% and 12% for adolescent and adults mice,
respectively.
Microbial diversity was only affected by ABX treatment
during adolescence
To investigate possible long-lasting effects of ABX
treatment during adolescence and adulthood on the gut
microbiota, microbiota was sequenced from caecal con-
tents 49 days after termination of the treatment. Overall,
sequencing demonstrated that the gut microbiota was
shifted only in ABXadolescence mice where ABX treatment
had reduced relative abundance and diversity compared
to CTRL (Fig. 2A–C). With regards to beta-diversity,
PERMANOVA identified significant differences between
CTRL and ABX treatment in adolescent mice (p < 0.001,
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Fig. 2 (See legend on next page.)
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R2= 0.193, padj= 0.004; Fig. 2A), but no such change was
observed in ABXadulthood (p= 0.029, R
2= 0.071, padj=
0.174; Fig. 2A).
Alpha diversity, which describes the diversity of species
within a community, was measured by calculating indices
for richness and evenness based on amplicon sequence
variants (ASV) level. Details of the statistics for each ASV
can be found on the Supplementary Table S2. Figure 2B
shows reduced numbers of bacterial species between
CTRL and ABX treatment in adolescent mice (Chao1
Index; pairwise comparison using Wilcoxon rank-sum
test, p < 0.001) while no changes were observed in
ABXadulthood mice. Moreover, a significant decrease in
evenness across ASVs was observed in ABXadolescence mice
(Shannon Index; pairwise comparison using Wilcoxon
rank-sum test, p < 0.001), indicating that treatment with
ABX during adolescence disrupted the uniformity of the
population size of each of the species present. No effects
of treatment during adolescence or adulthood were
observed for the Simpson’s index.
ABX treatment only resulted in significant long-
lasting changes in relative abundance of adolescent
mice. ABXadolescence mice showed reduced relative
abundance of most of the strains affected. At the phy-
lum level, Firmicutes and Bacteriodetes were most
affected by the ABXadolescence intervention (Fig. 2C).
Actinobacteria had a marginal shift that was restricted
to the genus Coriaobacteriaceae UCG002 and Parvi-
bacter, found increased, and Enterorhabdus, with mixed
result. Relative abundance of all the affected genera in
the phylum Bacteriodetes was decreased, with the
strongest reduction in the genera Bacteroides, while
Parabacteroides, Odoribacter and Alistipes had less
strong effect. Members of the Firmicutes phylum were
differentially in ABXadolescence. In the Lachnospiraceae
family, relative abundance of all affected ASV of the
genera Rosburia, UCG-001, UCG-004, UCG-010,
FCS020 group and Pseudobutyrivibrio were decreased,
whereas at UCG-006, NK4A136 group, Lachnoclos-
tridium and Blautia showed increased relative abun-
dance in ABXadolescence. Of the family Ruminococcaceae,
relative abundance of the genera UCG-003, UCG-009,
UCG-010 and UCG-013 was decreased while the genera
Ruminiclostridium 5, Ruminiclostridium 9 and Anae-
rotruncus was significantly increased. Similarly, one
ASV of the genus Lactobacillus was decreased while
another ASV of this genus was strongly increased fol-
lowing treatment with ABX. The relative abundance of
all affected ASVs of the family Family XIII and Ery-
spelotrihaceae was decreased. The phylum Proteo-
bacteria had just one family changed after ABX
treatment, where Parasutterella was found decreased.
In ABXadulthood, no significant effect on relative abun-
dance was observed. However, differences in relative
abundance were observed in CTRL or ABX groups
between adolescent and adults mice. As expected, CTRL
mice from adolescence and adults have different micro-
biota composition and diversity (Fig. 2A–C). When
comparing ABX treatment of adolescent versus adult
mice, relative abundance of most of the ASVs is increased
in ABXadulthood mice in comparison to ABXadolescence
treated mice and vice versa (e.g. ASVs of the genera
Parabacteroides and Odoribacter). This is in line with the
decrease observed in the comparison of relative abun-
dance of ABXadolescence mice and their controls. Similarly,
the differences seen between the controls of either treat-
ment is not in contradiction with the differences observed
in relative abundance of ABXadolescence mice in compar-
ison to their controls. The differences in relative abun-
dance between controls mostly occurred in ASVs that are
not affected in the ABXadolescence, 14 out of the 25 ASVs
that were different between the controls were not sig-
nificantly affected by ABXadolescence treatment (e.g. ASVs
of the genus Alistipedis).
Treatment with antibiotics strongly affected anxiety-like
behaviour, with a more pronounced effect in mice treated
during adolescence
To test the effects of ABX treatment on anxiety-like
behaviour, mice were tested in the EPM. Mice that under-
went antibiotic treatment showed increased anxiety-like
behaviour. Unpaired t-test with Welch’s correction showed
(see figure on previous page)
Fig. 2 Long-lasting changes in caecal microbiota composition following ABX intervention during adolescence. A PCA blots depicting
differences in beta-diversity between mice treated with ABX and their respective controls. While beta-diversity was affected by ABXadolescence
treatment no such effects were seen following ABXadulthood treatment. B alpha-diversity indices: Chao1, Shannon and Simpson. Changes in the Chao1
and Simpson indices are observed following treatment with ABX during adolescence but not after treatment in adulthood. C Heat map representing
relative abundance of ASVs. Significant differences were observed between control mice and ABX-treated mice during adolescence but not when
treated during adulthood. Some differences in ASVs were observed when comparing both ABX treatments and controls with one another. The latter
does not explain the effect on relative abundance of ABX treatment during adolescence. Mean ± SEM. *p < 0.05. Sample size for adolescence: CTRL
n= 12 and ABX n= 10; for adults: CTRL and ABX n= 11. A Permutational multivariate analysis of variance (PERMANOVA), followed by pairwise
PERMANOVA post hoc Benjamini–Hochberg, B Wilcoxon rank-sum test, post hoc Bonferroni, *p < 0.05, C Mann–Whitney U test post hoc
Benjamini–Hochberg, Benjamini–Hochberg false discovery rate (FDR) q < 0.2. Asterisks in the heat map represent the following q values: *p < 0.1, **p
< 0.01, ***p < 0.001.
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that the percentage of time into the open arms, as well as the
number of head dips (t= 2.846, p= 0.01 and t= 2.909,
p= 0.01, respectively; Fig. 3A, B), were affected significantly
in ABXadolescence mice. Student t-test showed that the per-
centage of entries into the open arms also was affected
significantly in ABXadolescence mice (t= 2.529, p= 0.02; Fig.
3C). Welch’s t-test revealed no statistical significance in the
percentage of entries into the open arm in ABXadulthood mice
(t= 1.946, p= 0.06; Fig. 3K). Mann–Whitney nonpara-
metric test found that the percentage of time into the open
arms as well as head dips were no difference in ABXadulthood
compared to the controls (U= 38, p= 0.148 and U= 38,
p= 0.145, respectively; Fig. 3I, J). Entries into the closed arm
did not differ between treatment groups (adolescence: t=
0.419, p= 0.68; adulthood: t= 0.449, p= 0.65; Fig. 3D, L),
indicating that ABX treatment did not affect locomotor
activity.
Sociability and memory processes were not affected by
antibiotic treatment in adolescence or adulthood
As social behaviour and cognition have been shown to
be impacted by alterations in gut microbiota composition,
we investigated the effects of ABX treatment on measures
in 3CSIT and NORT. ABX treatment during adolescence
or adulthood had no effects on sociability or social
novelty. Two-way repeated measures ANOVA found
preferential interaction for a stranger mouse (S1) over an
innate object (O) (S1 ×O: F(1,17)= 52.92, p < 0.001,
treatment: F(1,17)= 1.76, p= 0.20 for adolescence; S1 ×
O: F(1,20)= 60.54, p < 0.001, treatment: F(1,20)= 0.013,
p= 0.90 for adulthood, supplementary Fig. 1B, E,
respectively). Sidak’s multiple comparison post hoc test
found that CTRL and ABX from both adolescence and
adult groups preferred S1 over O (p < 0.0001). On social
novelty, two-way repeated measures ANOVA found that
only the adolescence group has a preference between
stranger and familiar mouse (S1 × S2: F(1,17)= 13.96, p <
0.01, treatment: F(1,17)= 3.03, p= 0.09 for adolescence;
S1 × S2: F(1,20)= 2.74, p= 0.11, treatment: F(1,20)=
0.61, p= 0.44 for adulthood, supplementary Fig. 1C, F,
respectively). Sidak’s multiple comparison post hoc test
found that ABX-treated adolescent preferred S1 over S2
(p < 0.001) but not CTRL-treated mice (p= 0.10).
In the NORT, neither ABXadolescence or ABXadulthood
exhibited differences in the ability to recognize a distinct
object 1 h after the training session, expressed by the time
exploring the novel object (adolescence: t= 1.233, df=
16.47, p= 0.23; adulthood: t= 0.5288, df= 16.77, p=
0.60, Supplementary Fig. 2A, D).
Fear learning is only affected in animals treated with
antibiotics during adolescence
Fear conditioning aimed to investigate different fear
responses, such as fear learning, contextual fear and cued
extinction (Fig. 3E–H, M–P). All experimental groups
learned the task as indicated by increasing freezing
behaviour during acquisition (two-way repeated measures
ANOVA; CS presentation, adolescence: F(4,68)= 38.11,
p < 0.001; adulthood: F(4,80)= 27.36, p < 0.001; Fig. 3E,
M). Only ABXadolescence mice significantly increased
freezing behaviour compared to the control group during
fear acquisition, while in adults, ABX did not affect fear
acquisition (two-way repeated measures ANOVA; treat-
ment, adolescence: F(1,17)= 4.48, p= 0.04; adulthood: F
(1,20)= 0.17, p= 0.67). Sidak’s multiple comparison post
hoc test did not find a significance between CTRL and
ABX in any timepoint in both adolescence and adults
mice. On day 2, contextual fear was assessed. Unpaired t-
test with Welch’s correction revealed that the treatment
did not affect freezing behaviour in adolescent mice (t=
1.70, p= 0.10; Fig. 3F). Student t-test revealed the same in
adult mice (t= 0.73, p= 0.47; Fig. 3N). In the cued
extinction session (day 3), the response to the CS (paired
sound) was analysed. All experimental groups reduced
their freezing response over the course of CS presentation
(CS presentation, two-way repeated measures ANOVA
adolescence: F(4,68)= 18.03, p < 0.001, adulthood: F
(4,80)= 15.15, p < 0.001; Fig. 3G, O), suggesting that all
experimental groups were able to extinguish cued fear.
Fear extinction was not affected by treatment (two-way
repeated measures ANOVA; adolescence: F(1,17)= 0.095,
p= 0.76, adulthood: F(1,20)= 0.11, p= 0.74). Pre and
post CS freezing were similar in ABX-treated mice com-
pared to their controls (Welch’s t-test; adolescence; pre: t
= 0.36, p= 0.72; post: t= 0.61, p= 0.54; adulthood; pre: t
= 0.22, p= 0.82; post: t= 0.15, p= 0.88), indicating the
absence of generalized fear. Fear recall was tested on day
four and no difference was observed (Welch’s t-test;
adolescence: t= 0.86, p= 0.39, adulthood t= 0.93, p=
0.36; Fig. 3H, P). Taken together, this data show that
transient depletion of the gut microbiota has little
potential to long-lasting affect fear response.
Amygdala gene expression is more strongly affected by
treatment during adolescence than adulthood
Many studies have demonstrated a link between the gut
microbiota and gene expression in the amygdala39,45. In
amygdala homogenates, mRNA levels revealed a stronger
effect of ABXadolescence than ABXadulthood treatment (Fig. 4
and Table 1). Immune markers were heavily affected by
ABX treatment during adolescence and adulthood (Fig. 4A,
E). For instance, elevated levels of Fcgr2b (Fc fragment of
IgG receptor IIb) gene were observed in both ABXadolescence
and ABXadulthood mice. The toll-like receptor 4 gene (Tlr4)
was oppositely affected by ABX treatment with elevated
gene expression following ABXadolescence treatment and
reduced expression after ABXadulthood treatment. In con-
trast, interleukin 1b (Il1b) was elevated following
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Fig. 3 ABX treatment during adolescence affects anxiety-like behaviour and the fear response during fear acquisition. A–D Mice treated
with ABX during adolescence showed increased anxiety-like behaviour as they showed decreased % time in and % entries into the open arm as well
as decreased number of head dips. I–L No significant decrease in anxiety-like behaviour was seen in mice treated with ABX during adulthood. E–H
An effect of treatment was seen for the acquisition of fear conditioning in mice treated with ABX during adolescence, but no other parameter was
affected. M–P Treatment with ABX during adulthood had no effect on any parameter measured in the fear-conditioning paradigm. Mean ± SEM.
A–D, F, H, I–L Welsh’s t-test comparison between CTRL and ABX. E, G, M, O two-way repeated measures ANOVA, followed by Sidak’s post hoc test
when applicable *p < 0.05 and **p < 0.01. Sample size for adolescence (CTRL: n= 9; ABX: n= 10) and adulthood (CTRL: n= 11; ABX: n= 11).
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Fig. 4 (See legend on next page.)
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ABXadulthood treatment but not following ABXadolescence
treatment, while the microglia-related gene C1qa (encodes
the A-chain polypeptide of serum complement sub-
component C1q) and Cx3cr1 (interleukin 8 receptor, alpha)
was only upregulated in ABXadolescence mice. Rac2 (Rho
GTPase Rac2), which regulates phagocytosis was upregu-
lated in both experimental groups. The complement com-
ponent 3 (C3) which is also involved in the regulation of
phagocytosis, was only upregulated in ABXadulthood mice.
Classical and peptidergic neurotransmission was strongly
affected by ABXadolescence treatment but remained mostly
unaltered in ABXadulthood mice (Fig. 4B, F). The levels of
gamma-aminobutyric acid receptor subunit alpha-2a
(Gabra2) and beta-1b (Gabrb1), the metabotropic gluta-
mate receptor subunit 5 (Grm5), neuropeptide Y (NPY) and
its Y1 receptor (Npy1r) and the glucocorticoid receptor
(Nr3c1) were only increased in ABXadolescence mice. The
corticotropin-releasing hormone receptor subunit 1 (Crh1r)
was the only gene affected in ABXadulthood mice, that was
not altered by ABXadolescence treatment. Neuroplasticity
genes were differently affected by ABXadolescence and
ABXadulthood (Fig. 4C, G). While the levels of postsynaptic
density protein 95 (Psd95) and synaptophysin (Syp) were
increased in ABXadolescence mice, these genes were down-
regulated following ABXadulthood treatment. Interestingly,
genes associated with short-chain fatty acids (SCFAs), the
solute carrier subtypes (Slc5a8 and Slc16a1) were only
elevated in ABXadolescence mice. Similarly, the gene expres-
sion of tight-junction genes, such as occludin (Ocln) and
tight-junction protein 1 (Tjp1) were only increased in
ABXadolescence mice. Taken together, although more genes
are affected in ABXadolescence, immune-related genes are
similarly affected by both ABX treatments.
Finally, we analysed myelination-related genes in the
prefrontal cortex, which have been suggested to be modu-
lated by the gut microbiota20,46. Therefore, we analysed gene
expression of myelin regulatory factor (Myrf), proteolipid
protein 1 (Plp1) and the transcription factor SOX-10
(Sox10). ABXadulthood treatment resulted in increased gene
expression of Myrf and Sox10 while ABXadolescence showed
no effects (Supplementary Fig. 2A, B).
Discussion
Adolescence is a particularly vulnerable time for the
onset of psychopathology. Understanding what factors
mediate such susceptibility is an important area in bio-
logical psychiatry research. In the present studies, we
assessed the long-term effects of transient gut micro-
biota depletion using an established ABX cocktail in
mice during adolescence or adulthood. ABXadolescence
had long-lasting effects on composition and structure of
the gut microbiota and anxiety-like behaviour, whereas
ABXadulthood had no effects. This long-lasting shift in the
gut microbiota when depleted during adolescence high-
lights the vulnerability of the gut microbiota during
development and may be responsible for the anxiety-like
phenotype and pronounced changes in gene expression
within the amygdala observed in ABXadolescence mice. To
our knowledge, this is the first study demonstrating that
the long-lasting effects on gut microbiota only occur
when treated during a critical developmental period.
In mammals, the initial microbiota is mainly acquired at
birth and later shaped during the developmental period by
genetics and environmental factors until become
increasingly stable and resistant during adulthood2,19,21.
Adolescence is a period when major physiological trans-
formation occurs. Sexual hormones such as testosterone
and oestrogen are peaking during puberty and it is known
to affect the composition of the gut microbiota2,47,48.
Comparatively, the gut microbiota during the adolescence
is less diverse, with a lower Firmicutes/Bacteriodetes ratio
than adults49. Consequently, environmental stressors such
as poor diet, antibiotics, exercise among other can impair
the gut microbiota differently in adolescence and adults,
with the later demonstrating higher resilience to harmful
events compared to adolescence or elderly.
Use of antibiotics strongly affect the Firmicutes/Bacter-
iodetes ratio16,18–20,25–27,50–52 and could be determinant to
(see figure on previous page)
Fig. 4 Amygdalar gene expression is more drastically changed following ABX treatment during adolescence. A, B While genes related to
neuroimmunity and microglia are similarly affected in ABXadolescence and ABXadulthood mice, gene expression genes involved in C, D
neurotransmission, E, F neuroplasticity, short-chain fatty acids and tight-junction proteins are more drastically affected in ABXadolescence mice. Mean ±
SEM. Unpaired t-test with Welch’s correction comparing vehicle and antibiotic treatment for each gene. *p < 0.05, **p < 0.01 and ***p < 0.001. Sample
size for adolescence: CTRL and ABX n= 8 (Il10, Il1b, Gabra2, Gabbr1, Npy1r, Psd95 and Tjp1), CTRL n= 8 and ABX n= 9 (Fcgr2b, Cx3cr1, Rac2, C3, C1qa,
Grm5, Chr1r, Npy, Syp, Ffar1, Slc5a8, Slc16a1, Ocln), CTRL n= 9 and ABX n= 8 (Tlr4), CTRL and ABX n= 9 (Nr3c1). Sample size for adults: CTRL and ABX
n= 9 (Fcgr2b, Il1b, Cx3cr1, Rac2, C3, Gabra2, Gabbr1, Grm5, Crh1r, Npy1r, Psd95, Syp, Ffar1, Slc5a8, Ocln, Tjp1), CTRL n= 10 and ABX n= 9 (Il10, Tlr4,
Nr3c1, Slc16a1), CRTL n= 9 and ABX n= 8 (C1qa, Npy). SCFA: short-chain fatty acid, C1qa: complement C1q subunit A, C3: complement component 3,
Crh1r: corticotropin-releasing hormone receptor 1, Cx3cr1: chemokine receptor 1, Fcgr2b: Fc fragment of IgG receptor IIb, Ffar1: free fatty acid receptor
1, Gabrb1: gamma-aminobutyric acid type B receptor subunit 1, Gabra2: gamma-aminobutyric acid type A receptor alpha2 subunit, Grm5: glutamate
metabotropic receptor 5, Il1b: interleukin 1b, Il10: interleukin 10, Npy: neuropeptide Y, Npy1r: neuropeptide Y receptor Y1, Nr3c1: glucocorticoid
receptor, Ocln: occludin, PSD95: postsynaptic density protein 95, Rac2: Ras-related C3 botulinum toxin substrate 2, Slc5a8: solute carrier family 5
member 8, Slc16a1: solute carrier family 16 member 1, Syp: Synaptophysin, Tjp1: tight-junction protein 1, Tlr4: toll-like receptor 4.
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facilitate changes in brain function and increase suscept-
ibility to anxiety levels33,49,52. Evidence has suggested that
changes in the microbiota composition can also regulate
sexual hormone production, which would have a larger
impact during the adolescence4,47,48. Thus, disrupting
normal growth trajectory of the gut microbiota and its
inability to bounce back to its original composition
following the treatment may have contributed to the long-
lasting effect after ABX treatment in adolescent53,54.
Many studies have described that 1–5 weeks of ABX
treatment is enough to deplete the gut microbiota and
influence the expression of genes and behaviour8,20,25,26.
By depleting the gut microbiota consistently over most of
the adolescence period, we observed a statistically
Table 1 Statistical values of the gene expression in the amygdala, prefrontal cortex following ABX intervention during
adolescence and adult.
Adolescent Adult
Gene t, df/U, t1/2 p t, df/U, t1/2 p
Amygdala
Fcgr2b t(W)= 4.732, df= 13.59 <0.001 t(W)= 2.167, df= 15.8 0.05
C1qa t(W)= 3.938, df= 13.16 <0.001 t(W)= 0.765, df= 14.37 0.46
Tlr4 t(W)= 5.658, df= 13.92 <0.001 U= 10; t1= 135, t2= 55 0.003
Il10 t(W)= 0.097, df= 11.27 0.92 U= 32; t1= 87, t2= 103 0.31
Il1B t(W)= 0.079, df= 12.96 0.94 t(W)= 2.356, df= 14.15 0.03
Cx3cr1 U= 1; t1= 37, t2= 116 <0.001 t(W)= 0.400, df= 15.72 0.69
Rac2 t(W)= 5.679, df= 9.484 <0.001 t(W)= 6.379, df= 11.64 <0.001
C3 t(W)= 1.643, df= 14.89 0.12 t(W)= 2.951, df= 15.29 0.01
Gabra2 t(W)= 5.427, df= 11.06 <0.001 U= 20; t1= 65, t2= 106 0.07
Gabrb1 t(W)= 3.42, df= 13.44 <0.001 U= 37; t1= 82, t2= 89 0.79
Grm5 t(W)= 8.899, df= 11.21 <0.001 t(W)= 0.409, df= 13.89 0.69
Psd95 U= 0; t1= 36, t2= 100 <0.001 t(W)= 3.724, df= 11.06 <0.001
Syp t(W)= 4.609, df= 13.46 <0.001 t(W)= 4.88, df= 13.49 <0.001
Npy t(W)= 5.087, df= 12.06 <0.001 t(W)= 0.865, df= 10.51 0.41
Nr3c1 t= 4.087, df= 16 <0.001 U= 39; t1= 106, t2= 84 0.64
Npy1r t(W)= 3.842, df= 8.787 <0.001 t(W)= 0.992, df= 11.31 0.34
Chr1r t= 0.2401, df= 15 0.81 U= 8; t1= 118, t2= 53 0.02
FFAR1 t(W)= 26; t1= 62, t2= 91 0.19 t(W)= 1.736, df= 12.16 0.11
Slc5a8 U= 4; t1= 40, t2= 113 <0.001 U= 30; t1= 75, t2= 96 0.38
Slc16a1 t(W)= 6.466, df= 12.82 <0.001 U= 21; t1= 76, t2= 114 0.05
Ocln t(W)= 3.641, df= 14.88 <0.001 0.34
Tjp1 t(W)= 3.759, df= 12.05 <0.001 t= 1.171, df= 16 0.26
Prefrontal cortex
Myrf U= 36; t1= 91, t2= 99 0.49 t(W)= 7.641, df= 14.12 <0.001
Plp1 t(W)= 0.489, df= 14.92 0.63 U= 45; t1= 111, t2= 120 0.49
Sox10 t(W)= 0.762, df= 16.89 0.46 t= 4.934, df= 19 <0.001
Mean ± SEM. Unpaired t-test with or without Welch’s correction or Mann–Whitney whenever the dataset did not follow normal distribution.
t Student t-test, t(W) Student t-test with Welch’s correction, df degree of freedom, U Mann–Whitney test, t1/2 sum of ranks of CTRL and ABX, C1qa complement C1q
subunit A, C3 complement component 3, Crh1r corticotropin-releasing hormone receptor 1, Cx3cr1 chemokine receptor 1, Fcgr2b Fc fragment of IgG receptor IIb, Ffar1
free fatty acid receptor 1, Gabrb1 gamma-aminobutyric acid type B receptor subunit 1, Gabra2 gamma-aminobutyric acid type A receptor alpha2 subunit, Grm5
glutamate metabotropic receptor 5, Il1b Interleukin 1b, Il10 interleukin 10, Myrfmyelin regulatory factor, Npy neuropeptide Y, Npy1r neuropeptide Y receptor Y1, Nr3c1
glucocorticoid receptor, Ocln occludin, Plp1 proteolipid protein 1, Psd95 postsynaptic density protein 95, Rac2 Ras-related C3 botulinum toxin substrate 2, Slc5a8 solute
carrier family 5 member 8, Slc16a1 solute carrier family 16 member 1, Sox10 SRY-box transcription factor 10, Syp synaptophysin, Tjp1 tight-junction protein 1, Tlr4 toll-
like receptor 4.
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significant increase in anxiety-like behaviour in the EPM
only in ABXadolescence mice, in line with the changes in
microbiota composition and structure. The role of gut
microbiota depletion in anxiety, however, is controversial
with studies describing a reduction of anxiety-like beha-
viours25,55, no effect20,26 or an anxiolytic effect following
microbiota depletion16. Firmicutes, Actinobacteria and
Bacteroides are known to affect anxiety levels, with lower
abundance being associated with elevated anxiety-like
behaviour in rodents and humans36,56–58. The stronger
effect observed in ABXadolescence mice over adults may also
have been influenced by sex hormones peaking during
adolescence. Preclinical and clinical studies in males
suggest that testosterone yields protective benefits against
anxiety. Moreover, high levels of testosterone during the
adolescent period is known to influence the commensal
bacteria Firmicutes/Bacteroides ratio4,47,48, suggesting
that interaction of ABX with testosterone during adoles-
cence could have an additive effect on the gut microbiota
composition.
In addition, it has been found that administration of
probiotics containing species of the genus Lactobacillus
and Bifidobacterium correlates with the expression of
Gabrb1 within the amygdala, an effect that has been
shown to be influenced by vagal communication36,59.
Interestingly, Lactobacilli species appeared mainly
increased and Bifidobacterium was unchanged in
ABXadolescence. Beneficial bacterial species such as Lac-
tobacillus and Bifidobacterium are usually found
decreased after ABX treatment in rodents60 and ele-
vated Lactobacillus/Bifidobacterium levels in the gut
microbiota or use of probiotic preparations have an
anxiolytic effect in rodents36,61–63. These comparisons
must be taken carefully since most of the previous
studies have not investigated the long-term effects of
gut microbiota depletion. Moreover, a study has found
that juvenile rodents react differently to treatment with
Lactobacillus, evoking an anxiogenic-phenotype fol-
lowing by changes in the gene expression and brain
function64, suggesting that the physiological mediators
peaking during the adolescent period may be playing a
role on the involvement of the Lactobacillus on the gut-
brain communication.
It is interesting to note that members of the family
Lachnospiraceae (in special NK4A136 group) and Bac-
teroides genus, which were decreased in ABXadolescence,
are also associated with anxiety in humans65,66 as well as
relevant to the production of SCFAs in rodents67. SCFAs
are important bacterial metabolites with neuroactive
properties67,68. Moreover, colonic SCFAs regulate intest-
inal barrier function69,70. Thus, a dysfunction in the
intestinal barrier can increase inflammatory response and
facilitate that peripheral substances escape into the
bloodstream and potentially reach the brain. Further
studies are needed to mechanistically unravel the path-
ways involved.
Interestingly, despite the body of literature showing that
the gut microbiota is implicated in social behaviour or
cognitive abilities17,20,25,26,50,71–74, we did not observe any
overt effect of ABX treatment in social behaviour and
short-term memory, suggesting that with the parameters
we used these phenotypes were not responsive to long-
lasting effects of gut microbiota depletion. Moreover, it
has been shown that deficient synaptic pruning, which is
associated with weak synaptic transmission and decreased
functional brain connectivity, is correlated with deficits in
social interaction and other neuropsychiatric disorders75.
These failures in the synaptic connectivity are due to the
lack of activity of the Cx3cr1 gene75,76. Cx3cr1 was found
upregulated in our study, suggesting a local role on brain
inflammatory response which is not directly associated
with sociability. In addition, fear conditioning which has
previously been shown to be modulated by microbiome
manipulations32,36,77 was only marginally affected by gut
microbiota depletion as only ABXadolecence mice showed
increased freezing behaviour during fear acquisition,
indicating that learning and memory indeed are not
overtly influenced by ABX treatment in this circum-
stances, despite all the changes observed on the gut
microbiota composition. To note, increased levels of
Lactobacillus species are described to improve cognition
process in rodents, including learning and memory61 but
not in a clinical study78.
Here we focused on the amygdala to understand to
which extent changes in gene expression could underly the
differences observed in the anxiety-like behaviour. Despite
the highest prevalence of overall gene expression changes
in ABXadolescence, the administration of ABX induced
similar disturbance for genes involved in neuroimmunity
response in ABXadolescence and ABXadulthood mice. Given
the importance of microglia in normal brain function, it is
not surprising that these genes have been associated with
the ABX treatment. The microglia-related genes Fcgr2b
and Rac2 were upregulated in both groups, while Cx3cr1
and C1qa were elevated only in ABXadolescence mice, con-
firming a role for microbiota recolonization observed in
ABXadulthood (but not in ABXadolescence) with restored
microglia features76. It has been suggested that elevated
levels of the Cx3cr1 ligand CX3CL1 is associated with pro-
neurogenic response by altering the environment in which
new cells are born79, suggesting that together with C1qa,
Cx3cr1 are playing a role in the prevention of chronic
inflammation induced by the gut microbiota depletion. In
fact, microglia seems to keep engulfing apoptotic debris
even after antibiotic treatment80, which together with ele-
vated Tlr4 expression followed by ABXadolescence treatment
could indicate certain level of neuroinflammation has been
occurring without the participation of the cytokines. In
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addition, it is well known that SCFAs directly affect
immune response with the intention to maintain homo-
eostasis by fine-tuning microglial function and production
of inflammatory cytokines, further suggesting that the
overexpression of the SCFAs transporters Slc5a8 and
Slc16a1 in the amygdala of ABXadolescence mice could be
related with the microbiome-derived factors that are
involved in modulate adaptive immune responses in the
brain. C3 is a downstream member of the component
cascade with an extremely versatile role that it is not
restricted to immune responses but also in tissue regen-
eration and synapse pruning81. Interestingly, C3 and Il1β
were elevated only in ABXadulthood. This could suggest that
neuronal loss and consequently cognitive deficits asso-
ciated with long-term depression caused by C3 could have
been counteracted by the production of Il1β, a cytokine
with a neuromodulatory role on neurogenesis82.
Tight-junction proteins at the blood-brain barrier are
known to be regulated by the gut microbiota, where the
decreased expression of these proteins is associated with
permeable blood-brain barrier83,84. Although gut deple-
tion is necessary to promote tight-junction protein
changes in the brain, the direction of these changes is
dependent on the brain region and protein tested. Herein,
we observed an upregulation of amygdalar Tjp1 and Ocln
only in ABXadolescence mice, confirming the role of deple-
ted gut microbiota on brain permeability26,84. Moreover,
this study also showed that the natural recolonization of
the gut microbiota is enough to recalibrate the function-
ality of the information transfer between the gut and brain
following a microbiota-targeted insult. Taken together,
our findings show that the immunological markers
changed in ABXadolescence and ABXadulthood mice are not a
result of a brain leakage through the blood-brain barrier
but probably due to local synthesis of volume diffusion
into the brain at the circumventricular organs that lack a
blood-brain barrier.
When examining the pattern of expression of genes
involved in neurotransmission it was clear that they were
more strongly affected in ABXadolescence than ABXadulthood
mice. Elevated brain levels of Crh1r has been found after
ABX treatment or in GF mice6,20 while downregulation of
the transcription levels of Crh1r has been found after
psychobiotics or SCFAs treatment in stressed animals67,85,
suggesting that restoration of the normal gut microbiota
could explain why we see altered Crh1r expression in
ABXadulthood mice. In addition, NPY and activation of
NPY1R are known to promote stress resilience and have
anxiogenic effects86–89. NPY locally influences GABAergic
activity through NPY1R, and both Npy and Npy1r were
found to be upregulated in chronic stress events90, in line
with the results observed in ABXadolescence mice. In fact,
evidence suggests that the gut microbiota may contribute
to resilience after repeated stress91–93. For instance, it has
been shown that chronic stress significantly increases gut
microbiota diversity in antibiotic-treated mice and can
neutralize not only stress-inducing anhedonia phenotypes
but also the levels of inflammatory markers, suggesting that
the development of susceptibility to stress in mice is sub-
jected to the composition of the gut microbiota93. Recently,
evidence has also confirmed that the use of commensal
bacteria strain to improve psychological functions and
cognitive health in stressed adult subjects58.
Interestingly, genes related with neuroplasticity, post-
synaptic density protein 95 (Psd95) and synaptophysin (Syp)
were oppositely affected by ABXadolescence and ABXadulthood,
suggesting a direct role of the gut microbiota composition
on the expression of these genes. A recent study has shown
that at least in the PFC, ABX treatment protects Psd95
expression from stress, suggesting that depleted gut
microbiota could play a role in the development of sus-
ceptibility in mice after stress93. However, in this study,
stress started after the ABX treatment, thus investigating the
role of stress during the recovery period of the gut micro-
biota, in agreement with previous literature that found
normalized levels of Syp and Psd95 after the restoration of
the gut microbiota9. Therefore, the upregulated expression
of these genes in ABXadolescence mice could be due to the
long-lasting shift in microbiota composition and structure,
whereas the decrease observed in ABXadulthood mice might
come from an exaggerated downregulation of these genes
due to a possible overexpression during the gut microbiota
depletion period.
Unexpectedly, ABXadulthood treatment seems also to play
a role in myelin-related gene. Recent studies have shown
upregulation of myelination-related genes in the PFC of
animals with disrupted gut microbiota, suggesting a role
for the gut microbiota in the formation of myelin37. Our
study indicates that depletion of the gut microbiota does
not exclusively affect myelination during critical devel-
opmental periods but can also influence myelination-
related gene expression in adulthood. Whether these
changes in gene expression translates to altered myeli-
nation, however, still needs to be investigated.
Overall, this study highlights vulnerability of the gut
microbiota during the adolescent period and the importance
of the microbiota during the developmental period in
shaping its host’s microbiota, brain function and behaviour.
A limitation of this study is that only males were tested. It is
worth pointing out that for the majority of our studies of
microbiota to brain interactions the effects are much more
robust in males94. However, much research is still needed to
unravel this interaction, and recent evidence suggests that
besides the sex bias for mental disorders, an interaction
between the sex, sex hormones and the gut microbiota is
highly possible with the gut microbiota94. Future studies will
determine how sex and sex hormones determine discrete
genes changes in the amygdala as well in the gut. Further,
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understanding what pathways of communication between
the gut and the brain are responsible for such changes at this
time period are also required. Interventions targeting the
vagus nerve or the use of specific dietary interventions
focused on specific populations of commensal bacteria that
are affected by ABX would be of further interest to provide a
mechanistic framework of the gut to brain signalling29,95.
Finally, as adolescence is a time where antibiotics are heavily
used clinically28, and its use is epidemiologically relevant to
the risk of several psychiatric conditions96, the results pre-
sented here support the need for further studies investigat-
ing their impact and their long-term effects on the
microbiota and associated risks to the brain function and
behaviour.
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